Alexandra Gunchenko

Alexandra Gunchenko currently serves as Vice President and Head of Clinical Sciences Early Clinical Development for Heme/Onc & Cell Therapy at Bristol Myers Squibb, a position held since November 2019. Prior to this role, Gunchenko was an Executive Director and Head of Hematology Clinical Research Scientist at Celgene from April 2013 to November 2019 and served as Senior Director and TA Lead Clinical Research Scientist in Heme/Onc. Earlier experience includes roles as Associate Director at Merck, Senior Clinical Trials Manager at Genta, Incorporated, and Oncology Nurse at Thomas Jefferson University Hospitals. Alexandra Gunchenko holds a BSN in Registered Nursing from Thomas Jefferson University and a Professional Coaching Certification from Georgetown University.